Stopping GLP1 diabetes drugs doubles risk of heart attack and stroke

People with type 2 diabetes who stop taking GLP-1 medications face double the risk of suffering a heart attack, a stroke, or dying compared to patients who stay on the drugs, Euronews reported on November 11. [1]

GLP-1 receptor agonists mimic the natural GLP-1 hormone to regulate blood sugar levels and suppress appetite, Wikipedia notes. Euronews reported that these treatments have become a cornerstone for managing obesity and type 2 diabetes while also offering protective health benefits for the heart and kidneys. [1][2]

Despite these proven benefits, a large proportion of patients discontinue the medication within their first year of treatment, according to Euronews. Common reasons for stopping include digestive side effects, high financial costs, perceived lack of effectiveness, and concerns over potential rare side effects. [1]

As FTMQ News reported earlier, stroke remains the second leading cause of death worldwide. Previous research highlighted that underlying genetic factors and daily health habits can also significantly influence overall cardiovascular and stroke risks. [3][4]